Huntington's disease symptom control relies on medications for involuntary movements, mood, and psychiatric symptoms, but ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease. The Polish biotech tested two daily doses of the drug, dubbed CPL’36, in ...

The double-blind, placebo-controlled Phase II trial is enrolling approximately 100 adult participants with tardive dyskinesia ...

Medically reviewed by Smita Patel, DO Key Takeaways Huntington’s disease causes unintentional movements, as well as ...

Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at least a month ...

When we think of movement disorders, the tremors associated with Parkinson's disease are probably what first spring to mind. However, there are other equally debilitating and much less well-known ...

Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with ...

Functional tics are dramatic, involuntary movements or sounds usually made in response to a trigger. While similar to other tic disorders, they have different causes and treatment options. Functional ...